Skip to main content

Oxaliplatin

ADVERTISEMENT
Identification
Molecular formula
C8H14N2O3
CAS number
61825-94-3
IUPAC name
2-[2-[13-amino-1-[1-(3,4-dicarboxybutanoyloxy)-2-methyl-hexyl]-5,10,12-trihydroxy-3-methyl-tetradecoxy]-2-oxo-ethyl]butanedioic acid
State
State

In its solid form, Oxaliplatin is a white to off-white crystalline powder.

Melting point (Celsius)
236.00
Melting point (Kelvin)
509.15
Boiling point (Celsius)
250.00
Boiling point (Kelvin)
523.15
General information
Molecular weight
397.30g/mol
Molar mass
397.2950g/mol
Density
2.7730g/cm3
Appearence

Oxaliplatin appears as a white or off-white crystalline powder.

Comment on solubility

Solubility of 2-[2-[13-amino-1-[1-(3,4-dicarboxybutanoyloxy)-2-methyl-hexyl]-5,10,12-trihydroxy-3-methyl-tetradecoxy]-2-oxo-ethyl]butanedioic acid

The solubility of the compound 2-[2-[13-amino-1-[1-(3,4-dicarboxybutanoyloxy)-2-methyl-hexyl]-5,10,12-trihydroxy-3-methyl-tetradecoxy]-2-oxo-ethyl]butanedioic acid (C8H14N2O3) can be influenced by a number of factors due to its complex structure, which comprises numerous functional groups. Here are some key points to consider:

  • Polarity: The presence of multiple hydroxyl groups and carboxylic acid functionalities indicates that the compound is likely to be polar.
  • Hydrogen Bonding: These polar functional groups promote extensive hydrogen bonding, which can enhance solubility in polar solvents such as water.
  • Hydrophobic Regions: The long hydrophobic alkyl chain may limit solubility in polar solvents, indicating that the compound may demonstrate variable solubility depending on the solvent.
  • pH Dependency: The solubility could also be pH-dependent due to the presence of acidic groups, influencing ionization and the overall solubility behavior.
  • Solvent Choice: It is expected that it would exhibit higher solubility in solvents that can engage in interactions with both polar and non-polar characteristics, such as mixed solvents.

In conclusion, while it is anticipated that this compound would show some solubility in polar solvents, its complex interactions and the balance between hydrophilic and hydrophobic characteristics call for detailed experimental evaluation to fully understand its solubility profile in various media.

Interesting facts

Interesting Facts about 2-[2-[13-amino-1-[1-(3,4-dicarboxybutanoyloxy)-2-methyl-hexyl]-5,10,12-trihydroxy-3-methyl-tetradecoxy]-2-oxo-ethyl]butanedioic acid

This fascinating compound, known by its complex name, showcases the intricacies and creativity found in the field of organic chemistry. Here are some intriguing details about this compound:

  • Biological Relevance: Compounds like this are often investigated for their potential roles in biological systems, particularly in metabolic pathways or as intermediates in the synthesis of bioactive molecules.
  • Amino Acid Derivative: The presence of the amino group highlights its classification as an amino acid derivative, which may influence its interactions with proteins and enzymes.
  • Functional Groups: The structure exhibits multiple functional groups, such as carboxylic acids and hydroxyl groups, suggesting potential for hydrogen bonding and reactivity. These functional groups are crucial for the compound's solubility and interaction with biological membranes.
  • Structural Complexity: Its elaborate structure indicates that this compound may undergo various conformational changes, impacting its reactivity and interaction with other molecules.
  • Synthetic Interest: Chemists may find this compound notable not just for its biological implications, but also for the challenges and techniques involved in its synthesis, making it a valuable target in synthetic organic chemistry.

In summary, 2-[2-[13-amino-1-[1-(3,4-dicarboxybutanoyloxy)-2-methyl-hexyl]-5,10,12-trihydroxy-3-methyl-tetradecoxy]-2-oxo-ethyl]butanedioic acid represents a unique intersection of structural complexity and biological functionality, making it an intriguing subject for research in both chemistry and biochemistry.

Synonyms
fumonisin b1
Macrofusine
116355-83-0
Macrofusin
Fumonisin B1-13C34 solution
NSC629151
1217458-62-2
Fungal metabolite from Fusarium monliforme
MLS000517270
SCHEMBL182918
CHEMBL1588379
DTXSID80861237
CHEBI:185259
HMS2268H15
1,2,3-Propanetricarboxylic acid, 1,-1'-[1-(12-amino-4,9,11-trihydroxy-2-methyltridecyl)-2-(1-methylpentyl)-1,2-ethanediyl] ester
2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,16,18-trihydroxy-5,9-dimethylicosan-7-yl}oxy)-2-oxoethyl]butanedioic acid
2-[2-[19-amino-6-(3,4-dicarboxybutanoyloxy)-11,16,18-trihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid
BCP31144
MSK7224C34-25M
SMP1_000324
NCI60_009465
SMR000127506
NS00000145
SR-01000721952
SR-01000721952-2
Fumonisin B1-13C34 Solution in Acetonitrile, 25ug/mL
2,2'-{(19-Amino-11,16,18-trihydroxy-5,9-dimethylicosane-6,7-diyl)bis[oxy(2-oxoethane-2,1-diyl)]}dibutanedioic acid
2-(2-((13-Amino-1-(1-((3,4-dicarboxybutanoyl)oxy)-2-methylhexyl)-5,10,12-trihydroxy-3-methyltetradecyl)oxy)-2-oxoethyl)succinic acid
2-[2-[13-amino-1-[1-(3-carboxy-5-hydroxy-5-oxo-pentanoyl)oxy-2-methyl-hexyl]-5,10,12-trihydroxy-3-methyl-tetradecoxy]-2-oxo-ethyl]butanedioic acid